FDA inspection
Glenmark Pharmaceuticals Inc USA: FDA inspection ending Jun 17, 2025
FDA inspection 1267093 · Voluntary Action Indicated (VAI) · Monroe, NC
Key facts
| Inspection ID | 1267093 |
|---|---|
| Firm | Glenmark Pharmaceuticals Inc USA |
| FEI number | 3011585599 |
| Address | 4147 Goldmine Rd |
| City | Monroe |
| State | NC |
| ZIP | 28110 |
| Country | United States |
| Fiscal year | 2025 |
| Inspection end date | Jun 17, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data